Celoxica, an Oxford University spin-out that makes chip design software, blamed “depressive market” conditions for the company raising less capital than it initially expected in its initial public offering
CellCentric, a biotechnology company specialising in epigenetics, is to sponsor a collaboration in cancer research at the Wolfson Institute of Biomedical Research, University College London.
US biotechnology firm DOR BioPharma plans to build a bigger force in gastro-intestinal medicines by buying Copenhagen-based Gastrotech Pharma, a spin-out of Gothenburg University in Sweden.
Shares in Oxford BioMedica, an Oxford University spin-out, fell 8.3 percent on news that the company was seeking up to £30 million to fund the Phase III trial of its a TroVax cancer immunotherapy product.
"Basic research may seem very expensive. I am a well-paid scientist. My hourly wage is equal to that of a plumber..." Albert Szent-Györgyi, Nobel-winning chemist
A microchip that mimics the function of the human brain could one day result in a mobile phone with the memory capacity of a desktop computer, researchers report.
Swati Piramal was born into a textile business family. And as typical Indian marriages were solemnized more than two decades ago, she too married into one of the oldest textile business families in Mumbai.
Philips is seeking to boost adoption of its clock-less integrated circuit technology, offering it at a knockdown price to universities and research institutions.
Despite the naysayers, more and more women are gaining success in the business of science. Our global investigation shows what it takes: good education, determination, a good employer, and some luck. Memo to government – Help them out.
A spin-out from the University of Southampton, UK, has a new “scintillation detector” that it says can help stop radiological threats at airports and elsewhere.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.